Borna disease is a viral brain infection that can affect horses, sheep, and rarely people. People with Borna disease may have fever, headache, confusion, and mood or behavior changes. Symptoms can worsen over days to weeks, and some infections can be severe or fatal without prompt care. Treatment focuses on supportive hospital care, and doctors may try antiviral or anti-inflammatory medicines. Not everyone will have the same experience, and early symptoms of Borna disease should be checked by a healthcare provider.
Overview
Borna diseaseSymptoms
Borna disease can start like a flu-like illness: fever, headache, tiredness, and muscle aches. As brain inflammation develops, people may have confusion, behavior changes, weakness, trouble walking, vision problems, or seizures. Early symptoms of Borna disease deserve urgent care.
Outlook and prognosis
Most people with Borna disease face a serious infection that can affect thinking, movement, and mood, and recovery varies. Early recognition, supportive care, and seizure and symptom control can stabilize health and improve comfort. Some recover partially; others have lasting neurologic changes.
Causes and risk factors
Borna disease results from infection with bornaviruses—most often BoDV‑1—that attack the nervous system. Risk increases with contact with reservoir or infected animals (e.g., shrews, exotic squirrels), animal care or wildlife work, residence in endemic Central Europe, and rarely organ transplantation.
Genetic influences
Genetics plays a limited role in Borna disease; infection with Borna disease virus is the key driver. Small genetic differences in immune response may influence susceptibility and illness severity. No single gene determines risk, and routine genetic testing isn’t recommended.
Diagnosis
Doctors suspect Borna disease in unexplained encephalitis and relevant exposure. Diagnosis of Borna disease uses RT‑PCR or broad viral panels on cerebrospinal fluid or brain tissue, plus serum/CSF antibodies and MRI findings, after ruling out more common infections.
Treatment and drugs
Treatment for Borna disease focuses on easing symptoms, supporting the nervous system, and preventing complications. Care may include antiviral therapy (such as ribavirin in select cases), anti‑inflammatory medicines, seizure control, and rehab for movement, balance, or speech changes. Regular follow‑up helps tailor care as needs change.
Symptoms
People with Borna disease often start with a vague sick-day feeling—tiredness, headache, and a mild fever. You might notice small changes at first: feeling off-balance, thinking a bit slower, or being unusually sensitive to light or noise. Early symptoms of Borna disease can resemble a flu-like illness and then shift over days to weeks into signs of brain inflammation, like confusion or trouble speaking. The course can move quickly, and not everyone has the same pattern.
Fever, chills, tiredness, and achy muscles can be the first signs. These can come with headache or nausea and may seem like a routine virus. When Borna disease advances, these early issues often give way to neurological symptoms.
Persistent or severe headache is common, sometimes with neck stiffness. Bright light or loud sounds may feel uncomfortable. If pain worsens or is sudden and intense, seek urgent care.
Feeling muddled, getting lost in familiar places, or not recognizing the date can develop as the brain becomes inflamed. Clinicians call this encephalitis, which means inflammation in the brain. In Borna disease, confusion can worsen over days.
Short-term memory can slip, and concentrating on conversations or tasks gets harder. What once felt effortless can start to require more energy or focus. People around you may notice repeated questions or missed appointments.
How people usually first notice Borna disease?
Many people first notice Borna disease after a sudden, flu-like illness shifts into worrying brain-related symptoms, such as confusion, behavior changes, or seizures. In animals and, rarely, in humans, the first signs of Borna disease can include fever, headache, and profound fatigue followed by neurologic problems like unsteady walking, speech difficulties, or unusual mood shifts, prompting urgent medical attention. Because it’s an infection rather than a birth condition, how Borna disease is first noticed usually centers on this rapid change from general sickness to signs of brain inflammation.
Types of Borna disease
Borna disease is caused by Borna disease virus (BDV), which mainly affects the brain and nerves. In animals it can be severe; in humans, confirmed disease is rare and still being clarified. Clinicians often describe Borna disease by how it shows up in the nervous system and by how quickly it develops. When people search for types of Borna disease, they’re usually asking how the presentation differs, so below are the commonly described clinical forms rather than distinct genetic variants or strains.
Acute encephalitis
Symptoms come on over days to a few weeks with high fever, headache, confusion, and drowsiness. People may develop seizures or weakness as brain swelling worsens. Hospital care is often needed to manage complications.
Subacute meningoencephalitis
Symptoms build over several weeks with persistent headache, light sensitivity, neck stiffness, and slowed thinking. Memory problems and mood changes can appear as inflammation spreads. Early symptoms of Borna disease in this form may look like a stubborn viral illness at first.
Chronic neurologic form
Ongoing inflammation leads to longer-term issues like concentration trouble, mood shifts, and balance problems. Some develop tremor or movement slowing that fluctuates day to day. The balance of symptoms can shift over time.
Brainstem-predominant form
Weakness of the face or swallowing muscles and double vision stand out early. People may notice hoarseness or trouble breathing if lower brain areas are involved. Close monitoring is important because small changes can affect breathing and heart rate.
Peripheral nerve involvement
Numbness, tingling, or burning pain in the hands and feet can occur alongside brain symptoms. Reflexes may be reduced, and weakness can spread in a “stocking-glove” pattern. Doctors look for this when limb symptoms don’t match brain imaging.
Ocular involvement
Blurry vision, eye pain, or seeing floaters can signal inflammation reaching the eyes. Light sensitivity and reduced color vision may follow. Eye exams help track changes and guide treatment decisions.
What genetics can tell you about symptoms
Some people with Borna disease tied to BoDV‑1 infection or related genetic susceptibility develop fever, headache, and mood or behavior changes that can progress to confusion and seizures. Variants affecting immune response genes may raise brain inflammation risk, worsening neurologic symptoms like weakness or movement problems.
Causes and risk factors
Borna disease is caused by bornaviruses carried by small wild mammals, mainly certain shrews.
People face risk when saliva, urine, feces, or dust from these animals gets into the eyes, nose, mouth, or broken skin.
Risk is higher in parts of Central Europe and in lifestyles with outdoor or farm work, gardening, handling small mammals, or keeping exotic squirrels.
A weak or suppressed immune system can raise the chance of severe disease, but there is no clear inherited genetic risk.
Doctors distinguish between risk factors you can change and those you can’t, and see a doctor promptly if you notice early symptoms of Borna disease in an affected area.
Environmental and biological risk factors
Borna disease is a rare brain infection mostly identified in certain parts of Central Europe. Risk tends to rise when people live or work near the small mammals that carry the virus, or when they disturb dusty spaces where these animals nest. Doctors often group risks into internal (biological) and external (environmental). Understanding these risks can help you seek care promptly if early symptoms of Borna disease arise.
Living or traveling in parts of Central Europe where the virus circulates in wildlife increases exposure chances. These include areas of Germany, Austria, and Switzerland with documented animal infections. People in these regions have a higher baseline risk of Borna disease.
A small insect-eating mammal called the bicolored white‑toothed shrew carries the virus long term. Touching shrews or cleaning places they nest can bring you into contact with infectious fluids.
Sweeping or blowing dusty sheds, barns, attics, or woodpiles in endemic areas can aerosolize dried droppings. Breathing in these fine particles may raise the chance of Borna disease.
Farmyards, gardens, and outbuildings that shelter small mammals create more opportunities for contact. Disturbed nesting materials or stored hay and wood can hold traces of the virus.
Genetic risk factors
Most cases of Borna disease are driven by infection with the Borna disease virus, not by inherited traits. So far, there’s no single gene that explains who develops it or how severe it becomes. Risk is not destiny—it varies widely between individuals. Research suggests host and viral genetics may influence the course, but clear, testable markers are still lacking.
No single-gene cause: Scientists have not found an inherited gene change that directly causes Borna disease. Current evidence points to many small genetic influences rather than one major gene.
Family patterns limited: This illness does not reliably run in families. Having a relative with the illness has not been shown to markedly raise your own risk.
Immune gene differences: Common differences in immune system genes may affect how your body handles the virus. These potential genetic risk factors for Borna disease are under study, and no specific change is confirmed for medical use.
Inherited immune disorders: Rare, inherited conditions that weaken immune defenses could make severe illness more likely. Borna-specific data are limited, but this pattern is seen with other viral brain infections.
Virus variant effects: Differences in the virus’s genes can influence how strongly it targets the brain. Animal and lab studies suggest some strains may be more damaging than others.
Inflammation control genes: Genes that help dial inflammation up or down might shape disease severity. Human evidence is early and not ready to guide screening or treatment.
No predictive testing: There is no validated genetic test to predict who will get Borna disease. Genetic testing is not recommended to assess personal risk at this time.
Lifestyle risk factors
Borna disease is a rare viral brain infection acquired through exposure to excretions of infected small wild mammals, especially in certain European regions. While personal habits do not cause the virus, everyday behaviors and hobbies can increase or decrease your exposure risk. The following lifestyle risk factors for Borna disease focus on activities that heighten contact with wild small mammals or contaminated dust and surfaces.
Gardening, mowing, or raking can aerosolize dust contaminated by small mammal droppings. Wearing a mask and dampening dusty areas may reduce inhalation exposure.
Catching, rescuing, or disposing of shrews or other small mammals increases contact with saliva, urine, or feces. Use tools and gloves instead of bare hands.
Cats that hunt shrews may bring infected prey into homes or gardens. Avoid handling prey with bare hands and clean areas where prey was found.
Farming, forestry, and veterinary work can involve frequent contact with small mammals or contaminated materials. Consistent use of gloves, masks, and handwashing lowers exposure.
Risk prevention
Borna disease is a very rare but serious brain infection in humans, linked to a virus that lives mainly in certain shrews in parts of Central Europe. There’s no vaccine yet, so prevention focuses on lowering exposure and catching concerning symptoms early, especially if you live in or travel to affected regions. Knowing your risks can guide which preventive steps matter most. If you’ve had contact with wild small mammals or are receiving an organ transplant, talk with your care team about specific precautions.
Avoid direct contact with shrews and their habitats (sheds, wood piles, barns), especially in parts of Germany, Austria, and Switzerland. Do not touch live or dead small wild mammals with bare hands.
Seal cracks, fit door sweeps, and repair screens to keep shrews out of living spaces and feed storage. Store pet food and grain in sealed containers and clear clutter where nests can form.
If you must clean droppings or nests, wear disposable gloves and a well-fitting mask. Lightly mist dusty areas to avoid stirring particles, and bag waste securely before disposal.
If a cat brings in a shrew or other small wild mammal, use gloves to remove it and dispose of it safely. Discourage hunting and keep pets out of sheds and barns where wildlife may shelter.
Transmission
Borna disease is caused by a virus carried mainly by certain small wild mammals, especially some shrews, and it can pass to people or farm animals after contact with these animals or their saliva, urine, or droppings. The exact route isn’t fully clear, but infection likely happens when contaminated material gets into the nose, eyes, mouth, or a cut, and occasionally through bites or scratches. Human-to-human spread of Borna disease hasn’t been documented, so it isn’t considered contagious through everyday contact. For most people the risk is very low and tends to be limited to regions where the virus circulates in wildlife. If you work with wildlife, handle exotic squirrels, or store feed where shrews may nest, using gloves, a mask when stirring up dusty areas, and careful handwashing can lower how Borna disease is transmitted.
When to test your genes
Borna disease is usually diagnosed by testing for viral infection, not routine genetic testing. Consider genetic testing only if a clinician suspects an inherited immune or neurologic condition that could change prevention or treatment. If you’ve had unexplained encephalitis, recurrent neurologic symptoms, or strong family history of immune disorders, ask your specialist.
Diagnosis
Early evaluation focuses on symptoms of brain inflammation—fever, headache, confusion, or seizures—that disrupt daily routines. Doctors usually begin with a neurological exam and basic tests, then move toward more specific viral studies as clues emerge; this is how Borna disease is diagnosed when it’s suspected. Tests may feel repetitive, but each one helps rule out different causes. Timing matters, because treatment and infection control decisions depend on a clear answer.
Providers review when symptoms started and how they changed over days to weeks. A rapid shift from flu-like symptoms to confusion or seizures raises concern for brain infection. Clear timelines help guide urgent testing.
Doctors check thinking, memory, coordination, reflexes, and cranial nerves. Findings like confusion, speech changes, or limb weakness can suggest inflammation in the brain. This exam helps prioritize urgent tests.
Blood work looks for signs of infection or inflammation. Results can point away from more common causes like bacterial infections or autoimmune flares. These tests also guide supportive care while waiting for specific results.
A sample of spinal fluid is collected to look for inflammation and infection. Lab teams measure cells, protein, and glucose and test for multiple viruses. Spinal fluid findings often narrow the list of likely causes.
Stages of Borna disease
Borna disease does not have defined progression stages. It usually appears as sudden brain inflammation that can get worse over days to weeks rather than moving through predictable long-term phases, and in people it’s so rare that a formal staging system hasn’t been set. Step by step, they look for the most likely explanations, using your health history, a neurological exam, and tests that assess the brain and spinal fluid. Doctors consider early symptoms of Borna disease—like fever, headache, confusion, or changes in behavior—alongside brain MRI and blood or spinal fluid tests for the virus to confirm the diagnosis and rule out other causes.
Outlook and prognosis
Looking at the long-term picture can be helpful. For many people with Borna disease, the course depends on how early the infection is recognized and how quickly supportive care begins. Early symptoms of Borna disease can look like the flu or a mood shift at first, then progress to confusion, trouble walking, or seizures; some may stabilize after the initial illness, while others need long-term neurologic care. When doctors talk about “remission,” they mean symptoms have eased or disappeared for a while, though lasting nerve or mood changes can remain.
The outlook is not the same for everyone, but severe brain inflammation from Borna disease can be life-threatening without prompt treatment. In outbreaks linked to BoDV-1 in parts of Central Europe, reported mortality has been high once encephalitis develops, while milder or possibly chronic cases described elsewhere appear to carry lower immediate risk but may leave lingering cognitive or psychiatric symptoms. With ongoing care, many people maintain day-to-day routines by pacing activity, using memory supports, and working with rehabilitation teams to regain strength and balance. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle.
Talk with your doctor about what your personal outlook might look like. They may review imaging, spinal fluid tests, and your recovery pattern to estimate the chance of relapse or lasting disability and to discuss work, driving, and support needs. Ask about early warning signs and what steps to take if they appear, such as new confusion, worsening headaches, or seizures, so you know when to seek urgent care. Genetic testing can sometimes provide more insight into prognosis when researchers are studying host factors that affect immune response, but it is not routinely used in clinical care today.
Long-term effects
Borna disease can cause inflammation of the brain that, for survivors, may leave lasting neurologic changes. Long-term effects vary widely, from mild memory lapses to significant problems with movement, speech, or mood. After early symptoms of Borna disease settle, some people recover well, while others need ongoing follow-up and rehabilitation. Over time, the pattern often becomes clearer, and your care team can adjust therapies to match your needs.
Short-term memory and focus may remain weaker than before. People with Borna disease often notice trouble recalling recent conversations or tasks.
Processing information can feel slower. Multi-step tasks or quick decisions may be harder than before Borna disease.
Planning, organizing, and switching between tasks can take extra effort. This can affect school, work, or managing daily routines.
Weakness, stiffness, tremor, or unsteady walking can persist. Falls risk may be higher, especially on stairs or uneven ground.
How is it to live with Borna disease?
Living with Borna disease can feel unpredictable, with periods of fatigue, slowed thinking, mood changes, or movement problems that make everyday tasks—work, school, driving, or managing finances—harder than they used to be. Symptoms can ebb and flow, so planning ahead, keeping routines simple, and leaning on reminders or checklists often helps. For many, the emotional toll—anxiety, low mood, or irritability—can be as challenging as the physical changes, and it affects partners, family, and friends who may need to adjust roles, offer practical support, and learn to recognize warning signs. With consistent medical care, mental health support, and patience from the circle around you, people can stabilize symptoms and protect day-to-day quality of life.
Treatment and drugs
Treatment for Borna disease focuses on easing symptoms and, when possible, reducing the virus’s activity. Care often includes rest, hydration, fever control with acetaminophen or ibuprofen, and careful monitoring for neurological symptoms such as confusion, seizures, or movement changes; in hospitals, people with severe Borna disease may need seizure medicines, fluids, and breathing support. Some clinicians use antiviral drugs like ribavirin or favipiravir based on limited laboratory and case reports, but evidence in humans is sparse, so your doctor may weigh potential benefits against side effects and discuss the uncertainties. If brain inflammation is suspected, specialists may add treatments to lower swelling and pressure in the brain while addressing complications such as electrolyte imbalances and secondary infections. Supportive care can make a real difference in how you feel day to day, and follow-up with neurology or infectious disease teams helps adjust care as your recovery progresses.
Non-drug treatment
For Borna disease, there’s no proven antiviral treatment, so care focuses on stabilizing the body and supporting the brain while it heals. Non-drug treatments often lay the foundation for recovery, whether someone is in intensive care or starting rehabilitation. Teams also watch for early symptoms of Borna disease—like sudden confusion, severe headache, or new weakness—because quick care can prevent complications. Plans are tailored to each person, as symptoms and recovery can vary widely.
Monitoring of brain, heart, and breathing helps catch problems early. Care teams manage fluids, blood pressure, and comfort while the brain recovers.
Oxygen or assisted breathing devices can protect the brain when breathing is weak. This helps maintain healthy oxygen levels during acute illness.
Keeping the head slightly elevated can lower pressure in the brain. Nurses also reduce bright light and noise to lessen irritation and headaches.
Cooling blankets or room adjustments can reduce high fevers. Lowering fever may ease headache and decrease brain stress.
Your genes may have an impact on how drugs work for you
Genes can change how your body processes antiviral or anti-inflammatory drugs for Borna disease, affecting speed of breakdown, side effects, and dose needs. Doctors may adjust medications based on genetics, liver function, and response to improve safety and effectiveness.
Pharmacological treatments
Borna disease is a rare viral brain infection, and there’s no medication proven to cure it yet. Treatments focus on experimental antivirals and careful hospital care to manage brain swelling, seizures, and other complications; early treatment of Borna disease may offer the best chance of benefit, though evidence is limited. Not everyone responds to the same medication in the same way. These medicines are usually given by specialists in high-level hospitals, often under compassionate or special-access pathways.
A broad-spectrum antiviral sometimes tried off-label for Borna virus encephalitis. Results have been mixed, and doctors monitor for anemia and liver effects.
An antiviral that has been used under special access in some cases. It may affect the liver and uric acid levels and should be avoided in pregnancy.
Interferon alfa or beta may be added for immune-modulating antiviral effects. Flu-like side effects are common, and it is sometimes combined with ribavirin.
Dexamethasone or methylprednisolone may be used to calm brain inflammation and reduce swelling. Benefits are uncertain and must be balanced against risks like high blood sugar and infection.
Genetic influences
In Borna disease, your genes likely play a smaller role than exposure to the virus itself. Some people wonder if Borna disease could be “in the genes.” Research so far doesn’t show that it runs in families; when several cases appear in the same household or stable, it’s usually due to shared environments or animal contact rather than inherited risk. That said, natural differences in immune system genes may shape how strongly the body responds to the virus and, in turn, how severe the illness becomes. No specific gene has been confirmed to raise the chance of getting Borna disease, and genetic testing isn’t part of routine care for this infection. If you’re concerned about genetic influences on Borna disease, talk with your doctor about practical steps guided by exposure risk where you live and your health history.
Is Borna disease genetic?
Genetics plays a limited role in Borna disease; infection with Borna disease virus is the key driver. Small genetic differences in immune response may influence susceptibility and illness severity. No single gene determines risk, and routine genetic testing isn’t recommended.
Pharmacogenetics—how genetics influence drug effects
Treatment for Borna disease often involves antivirals used for other infections, and people can respond quite differently to the same drug. Small genetic differences may change how quickly the body activates or clears medicines like ribavirin or favipiravir, which can affect both side effects and benefit. Not every difference in response is genetic, but genes linked to red blood cell handling of ribavirin have been tied to a higher or lower chance of anemia. Variants in enzymes that break down favipiravir may also influence drug levels, though this is still being studied, and pharmacogenetic testing for Borna disease is not routine today. Doctors will still base choices on factors such as age, kidney and liver function, other medicines, and pregnancy plans, while watching closely for side effects in Borna disease. As research grows, genetic information may help tailor Borna disease treatment more precisely, guiding dose or drug selection when options are limited.
Interactions with other conditions
For people with Borna disease, other health issues that weaken the immune system can influence how quickly the brain inflammation worsens and how severe symptoms become. Organ transplant recipients are a key example: infections have been passed through donor organs, and the illness can progress rapidly in those taking immune‑suppressing medicines. Doctors call it a “comorbidity” when two conditions occur together. Because the early phase can resemble autoimmune encephalitis or even a bad flu, receiving steroids or other immune‑suppressing treatments for the wrong diagnosis may unintentionally lower the body’s defenses against the virus. During intensive care, clinicians also watch for problems that often accompany serious brain infections, like bacterial pneumonia or blood clots, which can add to the recovery burden. If someone is living with kidney or liver disease, teams typically adjust drug choices and doses to reduce side effects while supporting the brain and vital organs.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described sudden changes in behavior and movement in animals and, at times, in people—episodes that puzzled healers long before modern tests existed. Community stories often described the condition as outbreaks among cavalry horses that became anxious, stumbled, or couldn’t coordinate their steps, especially in parts of central Europe. Caregivers in the past noticed that once one stable was affected, nearby stables sometimes saw similar illness, hinting at something contagious.
First described in the medical literature as a fatal neurologic illness in horses near the town of Borna in the late 1800s, this is known medically as Borna disease. Early reports focused on what could be seen: tremors, trouble swallowing, and dramatic shifts in behavior. Autopsies showed inflammation in the brain, but the cause remained unclear. Initially understood only through symptoms, later work began to suggest an infectious agent rather than a toxin or nutritional problem.
From early theories to modern research, the story of Borna disease moved steadily toward a viral explanation. By the mid to late 20th century, scientists isolated a unique virus from affected animal brains and showed it could spread and cause similar illness under experimental conditions. With each decade, lab methods improved, allowing researchers to detect the virus’s genetic material and trace how it travels within the nervous system. These steps confirmed that Borna disease virus can cause brain inflammation and neurologic symptoms in several animal species.
In recent decades, awareness has grown around related viruses that are carried by shrews and other small mammals in Europe and can, rarely, infect people. Historical differences highlight why careful wording matters: while Borna disease originally referred to a horse illness, newer findings describe “bornaviruses” as a broader family, some linked to severe encephalitis in humans. As medical science evolved, naming and classification shifted to reflect these discoveries.
Today, the historical arc helps explain the current picture. What started as mysterious outbreaks in horses became a model for understanding how a virus can persist in nerves, trigger inflammation, and lead to neurologic disease. Knowing the condition’s history reminds us why precise diagnosis, animal health monitoring, and careful lab confirmation are essential when doctors consider bornavirus infections, whether in veterinary settings or in rare human cases.